Preferences help
enabled [disable] Abstract
Number of results
2010 | 37 | 2 | 271-294
Article title

Co zmieniło się w leczeniu pacjentów ze wskazaniami do implantacji stymulatorów serca w ciągu ostatnich 5 lat

Title variants
What has changed in the treatment of patients with pacemaker implantation indication in the last five years?
Languages of publication
Wstęp: Celem pracy było porównanie typu i rodzaju implantowanych stymulatorów serca (PM) oraz zmian jakie dokonały się we wskazaniach do implantacji obowiązujących w roku 2004 i w 2009 roku. Metodyka: Badanie przeprowadzono w oparciu o dane Łódzkiego Rejestru Elektrostymulacji (LRE). Porównywano: dane epidemiologiczne, ilość i rodzaj wykonanych zabiegów, wskazania do implantacji, rodzaj implantowanego PM w roku 2004 (grupa 04) i 2009 (grupa 09). Wyniki: Do analizy włączono 711 pacjentów (pts): 281 pts w grupie 04 i 430 pts w grupie 09. W roku 2004 wykonano 234 implantacji, w roku 2009 - 280. W grupie 09 zwiększyła się ilość reimplantacji - 34,9% wszystkich zabiegów (2004 r. - 16,7%). Blok przedsionkowo-komorowy (p-k) II i III stopnia zarówno w 2004 r. i w 2009 r. był głównym wskazaniem do implantacji PM (ponad 40%). W 2009 r. ponad 90% pts w przebiegu zespołu bradykardia-tachykardia (BTS) miało zastosowany fizjologiczny tryb stymulacji DDDR. W utrwalonym migotaniu przedsionków w roku 2004 jak i 2009 implantowano PM VVI, ale w 2009 roku były to wyłącznie stymulatory „rate adaptive”. W 2009 roku 6% pts miało implantowany stymulator jako metodę leczenia niewydolności serca.
Introduction: The aim of the following study was a comparison of the types of the implanted cardiac pacemakers (PM) and the changes which took place in the guidelines for the implantation of the PM being used in 2004 and 2009. Methods: The study was performed based on the data from the Łódzki Rejestr Elektrostymulacji (LRE). Comparison of epidemiological data, PM types and modes and types of the performed procedures in 2004 and 2009 was assessed. Results: The final study included 711 patients (pts): 281pts in 2004 and 430pts in 2009. In 2004 234 new implantations were performed wheras in 2009 – 280. In 2009 the number of reimplantations increased and constituted 34.9% of all the procedures (in 2004 – 16.7%). Atrioventricular blocks (2nd and 3rd degree) were the main indication for the implantation of PM both in 2004 and 2009 (exceeding 40%). In 2009, more than 90% of pts with the BTS were being applied the physiological type of the DDDR stimulation. In chronic Atrial Fibration (AF), both in 2004 and 2009, PM VVI were implanted – in the 2009 group only the PM “rate adaptive” were used. In the 2009 in 6% of pts cardiac resynchronization PM were implanted as the heart failure indication.
Physical description
  • Zakład Elektrokardiologii, I Katedry Kardiologii i Kardiochirurgii, Uniwersytet Medyczny w Łodzi
  • Zakład Elektrokardiologii, I Katedry Kardiologii i Kardiochirurgii, Uniwersytet Medyczny w Łodzi
  • Zakład Elektrokardiologii, I Katedry Kardiologii i Kardiochirurgii, Uniwersytet Medyczny w Łodzi
  • Centrum Komputerowe Politechniki Łódzkiej
  • Klinika Kardiochirurgii I Katedry Kardiologii i Kardiochirurgii, Uniwersytet Medyczny w Łodzi
  • Zakład Elektrokardiologii, I Katedry Kardiologii i Kardiochirurgii, Uniwersytet Medyczny w Łodzi
  • Nelson G. A brief history of cardiac pacing. Tex Heart Inst J. 1993; 20:12-18.
  • Gold M. Permanent Pacing: new indications. Heart. 2001; 86:335-360.
  • Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK i wsp. Pacemaker Selection in the Elderly Investigators: quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dualchamber pacing. N Engl J Med. 1998; 338:1097–1104.
  • Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM i wsp. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med. 2000; 342:1385–1391.
  • Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R i wsp. For the Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002; 346:1854–1862.
  • Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol. 2003; 42:614–623.
  • Connolly SJ, Kerr C, Gent M, Yusuf S. Dual-chamber versus ventricular pacing. Critical appraisal of current data. Circulation. 1996; 94:578–583.
  • Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA i wsp. ACC/AHA/- NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. Circulation. 2002; 106:2145-2161.
  • Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H i wsp. Guidelines for cardiac pacing and cardiac resynchronization therapy European Heart Journal. 2007; 28:2256–2295.
  • Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A i wsp. The Euro Heart Failure Survey Programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003; 24:464 474.
  • Van Veldhuisen DJ, Charlesworth A, Crijns HJGM, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J. 1999; 20:666–672.
  • The EHRA White Book. July 2008 EHRA/publications/Documents/ehra-white-book-2008.pdf.
  • The EHRA White Book. July 2009 EHRA/publications/Documents/ehra-white-book-2009.pdf.)
  • Samartin RC. Estado actual de la estimulacion cardiac permanente en Espana. Informe del Banco Nacional de Datos de Marcapasos. Rev Esp Cardiol.1997; 50:760-765.
  • Styliadis IH, Mantziari AP, Gouzoumas NI, Vassiliokos VP, Paraskevaidis SA, Mochlas ST i wsp. Indications for Permanent Pacing and Pacing Mode Prescription from 1989 to 2006. Experience of a Single Academic Centre in Northern Greece. Hellenic J Cardiol. 2008; 49:155-162
  • Cunningham D, Rickards T, Cunningham M. National Pacemaker Database. Annual report 2002:
  • Veerareddy S, Arora N, Caldito G, Reddy PC. Gender differences in selection of pacemakers: a single-center study. Gend Med. 2007; 4:367-373.
  • Specialty Group for cardiac pacemakers, German National Agency for Performance and Measurement in Health Care. German Pacemaker Register, report 2003.
  • Horvat D. The first seven years of implantation of permanent cardiac pacemakers in a small urban community in central Croatia. Acta Clin Croat. 2008; 47:227-230.
  • Sutton R, Bourgeois I. Cost benefit analysis of single and dual chamber pacing for sick sinus syndrome and atrioventricular block. An economic sensitivity analysis of the literature. Eur Heart J. 1996; 17:574-582.
  • Samartín CR, Ferrer MJ, Tello SMJ, Mateas RF, Leal del Ojo González J Spanish Society of Cardiology Working Group on Cardiac Pacing Spanish Pacemaker Registry. Fifth official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2007). Rev Esp Cardiol. 2008; 61:1315-1328.
  • Tang AS, Roberts RS, Kerr C, Gillis AM, Green MS, Talajic M i wsp. Relationship between pacemaker dependency, the effect of pacing mode on cardiovascular outcomes. Circulation. 2001; 103:3081–3085.
  • Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK i wsp. Quality of life, clinical outcomes in elderly patients treated with ventricular pacing as compared with dualchamber pacing. The Pacemaker Selection in the Elderly Investigators. N Engl J Med. 1998; 338:1097–1104.
  • Toff WD, Camm AJ, Skehan DJ. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. The United Kingdom Pacing, Cardiovascular Events (UKPACE) Trial Investigators. N Engl J Med. 2005; 353:145–155.
  • Improving Clinical Outcomes In Chronotropic Incompetence: Case Studies - Kenneth Ellenbogen, Karoly Kaszala: 724498
  • Kristensen L, Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR. AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/ AAIR pacemaker. Pacing Clin Electrophysiol. 2001; 24:358–365.
  • Brandt J, Anderson H, Fahraeus T, Schuller H. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol. 1992; 20:633–639.
  • Lonyai A, Dubin AM, Feinstein JA, Taylor CA, Shadden SC. New insights into pacemaker lead-induced venous occlusion: simulation-based investigation of alterations in venous biomechanics. Cardiovasc Eng. 2010; 10:84-90.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.